ISSN 2149-2263 | E-ISSN 2149-2271
The Anatolian Journal of Cardiology
Atrial fibrillation in hypertrophic cardiomyopathy: mechanisms, embolic risk and prognosis [Anatol J Cardiol]
Anatol J Cardiol. 2006; 6(Suppl 2): 40-43

Atrial fibrillation in hypertrophic cardiomyopathy: mechanisms, embolic risk and prognosis

Ajith Nair1, Avi Fischer1
The Zena and Michael A. Weiner Cardiovascular Institute, Mount Sinai Medical Center, New York, NY, USA

Hypertrophic cardiomyopathy (HCM) is associated with an increased incidence of supraventricular and ventricular arrhythmias. Atrial fibrillation (AF) is the most common arrhythmia in HCM with a prevalence of 20% and an annual incidence of two percent per year. Inc- reased left atrial size and volume along with impaired left atrial function confer an increased likelihood of AF. The onset of AF is often accompanied by a decrease in functional status in conjunction with an increased risk of stroke and overall mortality.

Keywords: Atrial fibrillation, hypertrophic cardiomyopathy, thromboembolism

Ajith Nair, Avi Fischer. Atrial fibrillation in hypertrophic cardiomyopathy: mechanisms, embolic risk and prognosis. Anatol J Cardiol. 2006; 6(Suppl 2): 40-43
Manuscript Language: English


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search



Copyright © 2024 The Anatolian Journal of Cardiology



Kare Publishing is a subsidiary of Kare Media.